The Anatomical Location Shapes the Immune Infiltrate in Tumors of Same Etiology and Affects Survival
Open Access
- 1 January 2019
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 25 (1) , 240-252
Abstract
Purpose: The tumor immune microenvironment determines clinical outcome. Whether the original tissue in which a primary tumor develops influences this microenvironment is not well understood. Experimental Design: We applied high-dimensional single-cell mass cytometry [Cytometry by Time-Of-Flight (CyTOF)] analysis and functional studies to analyze immune cell populations in human papillomavirus (HPV)–induced primary tumors of the cervix (cervical carcinoma) and oropharynx (oropharyngeal squamous cell carcinoma, OPSCC). Results: Despite the same etiology of these tumors, the composition and functionality of their lymphocytic infiltrate substantially differed. Cervical carcinoma displayed a 3-fold lower CD4:CD8 ratio and contained more activated CD8+CD103+CD161+ effector T cells and less CD4+CD161+ effector memory T cells than OPSCC. CD161+ effector cells produced the highest cytokine levels among tumor-specific T cells. Differences in CD4+ T-cell infiltration between cervical carcinoma and OPSCC were reflected in the detection rate of intratumoral HPV-specific CD4+ T cells and in their impact on OPSCC and cervical carcinoma survival. The peripheral blood mononuclear cell composition of these patients, however, was similar. Conclusions: The tissue of origin significantly affects the overall shape of the immune infiltrate in primary tumors.Keywords
All Related Versions
Funding Information
- Dutch Cancer Society (2014-6696)
- Dutch Cancer Society (2016-10726)
This publication has 46 references indexed in Scilit:
- PD-1–Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck CancerCancer Research, 2013
- The Biology and Life-Cycle of Human PapillomavirusesVaccine, 2012
- Infiltrating lymphocytes and human papillomavirus‐16–associated oropharyngeal cancerThe Laryngoscope, 2011
- CD161 defines effector T cells that express light and respond to TL1A-DR3 signalingEuropean Journal of Microbiology and Immunology, 2011
- IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platformJournal of Experimental Medicine, 2010
- An Unexpectedly Large Polyclonal Repertoire of HPV-Specific T Cells Is Poised for Action in Patients with Cervical CancerCancer Research, 2010
- HIV-1 sexual transmission: early events of HIV-1 infection of human cervico-vaginal tissue in an optimized ex vivo modelMucosal Immunology, 2010
- The Tumor Microenvironment: The Making of a ParadigmCancer Microenvironment, 2009
- Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania majorNature Medicine, 2007
- Papillomaviruses and cancer: from basic studies to clinical applicationNature Reviews Cancer, 2002